Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 1.00 |
| ▸ | ABCC4 | O15439 | 1/20 | 1.00 |
| ▸ | LMNA | P02545 | 4/20 | 0.60 |
| ▸ | TSHR | P16473 | 1/20 | 0.60 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.60 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.57 |
| ▸ | TERT | O14746 | 3/20 | 0.54 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.54 |
| ▸ | PPARG | P37231 | 3/20 | 0.54 |
| ▸ | PPARD | Q03181 | 3/20 | 0.54 |
| ▸ | PPARA | Q07869 | 3/20 | 0.54 |
| ▸ | BLM | P54132 | 2/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.54 |
| ▸ | FABP4 | P15090 | 2/20 | 0.54 |
| ▸ | F7 | P08709 | 2/20 | 0.54 |
| ▸ | F3 | P13726 | 2/20 | 0.54 |
| ▸ | GMNN | O75496 | 1/20 | 0.54 |
| ▸ | USP2 | O75604 | 1/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4364731 | 1.00 | MAPT (1.00) | MAPTABCC4LMNATSHRNFKB1 | |
| SCHEMBL2798059 | 1.00 | MAPT (1.00) | MAPTABCC4LMNATSHRNFKB1 | |
| SCHEMBL465896 | 1.00 | MAPT (1.00) | MAPTABCC4LMNATSHRNFKB1 | |
| SCHEMBL2492081 | 1.00 | MAPT (1.00) | MAPTABCC4LMNATSHRNFKB1 | |
| Undecylenic Acid SCHEMBL4464618 | 1.00 | MAPT (1.00) | MAPTABCC4LMNATSHRNFKB1 | |
| Undecylenic Acid SCHEMBL5974072 | 1.00 | MAPT (1.00) | MAPTABCC4LMNATSHRNFKB1 | |
| SCHEMBL7576245 | 1.00 | MAPT (1.00) | MAPTABCC4LMNATSHRNFKB1 | |
| Undecylenic Acid SCHEMBL17827 | 1.00 | MAPT (1.00) | MAPTABCC4LMNATSHRNFKB1 | |
| SCHEMBL481539 | 1.00 | MAPT (1.00) | MAPTABCC4LMNATSHRNFKB1 | |
| SCHEMBL466094 | 1.00 | MAPT (1.00) | MAPTABCC4LMNATSHRNFKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7541406-B2 | Phase change inks containing curable isocyanate-derived compounds | XEROX CORPORATION (US) | 2009-06-02 | — | — | US | claimed |
| US-20070123642-A1 | Phase change inks containing curable isocyanate-derived compounds | XEROX CORPORATION | 2007-05-31 | — | — | US | claimed |
| US-20070120909-A1 | Phase change inks containing curable isocyanate-derived compounds and phase change inducing components | XEROX CORPORATION | 2007-05-31 | — | — | US | claimed |
| US-20260035391-A1 | SILANE COMPOUND | DAIKIN INDUSTRIES, LTD. (JP) | 2026-02-05 | — | — | US | disclosed |
| EP-4678645-A1 | SILANE COMPOUND | Daikin Industries, Ltd. (JP) | 2026-01-14 | — | — | EP | disclosed |
| US-12522686-B2 | Method for producing hydroxy-fatty-acid-based polyols | U. WINDMÖLLER INNOVATION GMBH & CO. KG (DE) | 2026-01-13 | — | — | US | disclosed |
| WO-2024214748-A1 | SILANE COMPOUND | ダイキン工業株式会社 | 2024-10-17 | — | — | WO | disclosed |
| CN-117222414-A | Compounds for activating constant natural killer T-cells and methods for eliminating inflammatory senescent cells | 脱落性治疗公司 | 2023-12-12 | — | — | CN | disclosed |
| US-20230312805-A1 | METHOD FOR PRODUCING HYDROXY-FATTY-ACID-BASED POLYOLS | UNIVERSITÄT BIELEFELD (DE) | 2023-10-05 | — | — | US | disclosed |
| EP-4150103-A1 | METHOD FOR PRODUCING HYDROXY-FATTY-ACID-BASED POLYOLS | U. Windmöller Innovation GmbH & Co. KG (DE) | 2023-03-22 | — | — | EP | disclosed |
| EP-2802457-B1 | DIGITAL PRINTERS | HEWLETT PACKARD DEVELOPMENT CO (US) | 2019-04-10 | — | — | EP | disclosed |
| EP-1509536-A1 | FLUORINATED PHOSPHONIC ACIDS | 3M Innovative Properties Company (US) | 2005-03-02 | — | — | EP | disclosed |
| US-6824882-B2 | WATERPROOFING, CORROSION RESISTANCE PROTECTIVE COATINGS | 3M INNOVATIVE PROPERTIES COMPANY | 2004-11-30 | — | — | US | disclosed |
| WO-2003102003-A1 | FLUORINATED PHOSPHONIC ACIDS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2003-12-11 | — | — | WO | disclosed |
| US-20030228469-A1 | Fluorinated phosphonic acids | 3M INNOVATIVE PROPERTIES COMPANY | 2003-12-11 | — | — | US | disclosed |
| US-20020099155-A1 | Process for producing polar olefin copolymer and polar olefin copolymer obtained thereby | MITSUI CHEMICALS, INC. (JP) | 2002-07-25 | — | — | US | disclosed |
| EP-1170308-A2 | Process for producing a copolymer of a non-polar olefin and a polar olefin and the copolymer obtained thereby | Mitsui Chemicals, Inc. (JP) | 2002-01-09 | — | — | EP | disclosed |
| EP-1091958-A1 | SALTS OF PAROXETINE | SMITHKLINE BEECHAM PLC (GB) | 2001-04-18 | — | — | EP | disclosed |
| WO-2000001692-A1 | SALTS OF PAROXETINE | SMITHKLINE BEECHAM PLC (GB) | 2000-01-13 | — | — | WO | disclosed |
| US-4450149-A | REASCTING AN ORGANIC BORANE WITH A RADIOACTIVE HALOMONOCHLORIDE AND A MILD OXIDIZER; RADIOLOGY | RESEARCH CORPORATION (US) | 1984-05-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260035391-A1 | SILANE COMPOUND | OXER1, CBR1, MSR1 | MAPT 3787/4885ABCC4 3555/4885LMNA 2113/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.